Provider
Interleukin-31 (IL-31) Inhibitor - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Documents & Forms Results
Displaying 31 - 40 of 3279 results
Provider
Interleukin-31 (IL-31) Inhibitor - Medicaid
Program effective Date: Sep 01, 2025
Provider
Interleukin-13 (IL-13) Antagonist - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Interleukin-13 (IL-13) Antagonist - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Interleukin-4 (IL-4) Inhibitors - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Otezla (apremilast) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Oral Anticoagulant - Commercial
Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Otezla (apremilast) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Neurotrophic Keratitis - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Provider
Neurotrophic Keratitis - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025